Target intelligence / Profile preview

MT-CO1 pseudogene 22 (MTCO1P22)

Target
MTCO1P22
Molecular classification
Pseudogene
01

Overview

MTCO1P22 (MT-CO1 pseudogene 22) is a nuclear-encoded pseudogene, resulting from the retrotransposition or translocation of mitochondrial cytochrome c oxidase subunit I (MT-CO1) gene sequence into the nuclear genome. It is annotated as a non-protein-coding sequence and does not contribute to cytochrome c oxidase activity. Unlike its functional mitochondrial counterpart (MT-CO1), MTCO1P22 has no demonstrated biological function, clinical relevance, or drug interactions. Its existence is a remnant of genome evolution and serves as a genetic artifact rather than a molecular target. In summary, MTCO1P22 is a pseudogene and not a therapeutic target, with no known biological function, disease relevance, or drug interactions. Its annotations are correct and current, but its clinical and pharmacological relevance is null.

Other names
MTCO1P22MT-CO1 pseudogene 22mitochondrially encoded cytochrome c oxidase I pseudogene 22
02

Mechanism of action

None (no mechanisms, since it's not a functional or druggable entity)

03

Biological functions

None (does not encode a functional protein; pseudogenes generally lack biological function)
04

Disease associations

None (no disease roles assigned to pseudogenes like MTCO1P22)
05

Safety considerations

None (no safety or therapeutic challenges related to this pseudogene)
06

Interacting drugs

None (no known drugs interact with this pseudogene)
07

Biomarkers

None (not used as a biomarker in clinical or research settings)

Beyond the preview

Go deeper on MT-CO1 pseudogene 22 (MTCO1P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-CO1 pseudogene 22 (MTCO1P22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call